Summit Therapeutics Inc.

NasdaqGM:SMMT Stock Report

Market Cap: US$14.7b

Summit Therapeutics Inc. Company Information

Summit Therapeutics Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Summit Therapeutics Inc.
  • Ticker: SMMT
  • Exchange: NasdaqGM
  • Founded: 2003
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$14.749b
  • Shares Outstanding: 737.45m
  • Website: https://www.summittxinc.com

Number of Employees

Location

  • Summit Therapeutics Inc.
  • 601 Brickell Key Drive
  • Suite 1000
  • Miami
  • Florida
  • 33131
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SMMTNasdaqGM (Nasdaq Global Market)YesNew Ordinary SharesUSUSDMar 2015
SMMT *BMV (Bolsa Mexicana de Valores)YesNew Ordinary SharesMXMXNMar 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/20 11:20
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.